top of page
iStock-1393467576.jpg

BRINGING CONTINUOUS DATA TO THERAPY MANAGEMENT

Injectsense exists at the intersection of advanced semiconductor technology and medical systems.

We develop implant-based digital health systems to provide medical staff with continuous long-term data for improved therapy management.

OUR DNA

Combining the Best of Microelectronics and Medical Devices

Injectsense stands apart from other device developers thanks to its deep roots in two worlds: semiconductor and medical systems. We combine years of hands-on engineering experience in advanced microtechnology -- including ultra-low power IC design, telemetry and miniaturization -- with medical market, regulatory, software, and device expertise.

 

Our cross-functional approach has bridged these domains, yielding a number of innovative patent-pending solutions. Our Silicon Valley technical team has years of design and fabrication experience in semiconductor, wireless communications, and wafer-scale volume manufacture, while our Twin Cities team brings decades of commercial medical system and software development. 

iStock-1191463127.jpg
Our DNA

Leadership

IMG_8234_edited.jpg

Ariel Cao 
Co-founder
President & CEO

Unknown.png
519.jpg

Ates Gurcan 
VP Engineering

Unknown.png
IMG_1368.jpg

Kevin Berg
COO
Lead, Medical Systems

Unknown.png
1516252621811.jpeg

Cenk Acar
Co-founder
VP MEMS

 

Unknown.png
Leadership
Advisory Board

Medical Advisory Board

OPHTHALMOLOGY

glaucoma-center-ahmed.jpg

Iqbal "Ike" Ahmed, MD, FSCRC

Moran Eye Center

Screen Shot 2022-06-03 at 5.51.23 PM.png

Jason Bacharach, MD FAAO

California Pacific Medical Center

CB portrait_edited.png

Christophe Baudoin, MD

Institut de la Vision, Paris

AntoineBrezinPhoto.png

Antoine Brezin, MD, Ph.D.

Paris Cite University

School of Medicine

collazo-profile.jpg

Ernesto Collazo, MD, FAAO

Collazo Eye

flanagan250_edited.jpg

John G. Flanagan, Ph.D. FAAO

Berkeley School of Optometry

Lindstrom 118x142.jpg
David Richardson ASCRS 2018 Headshot (2)

Richard Lindstrom MD, FAAO

Minnesota Eye Consultants

David Richardson MD

San Marino Eye

Sinclair Web Bio.jpg

Stephen Sinclair, MD FAAO

Sinclair Retinal Associates

Unknown.jpeg

Kuldev Singh, MD

Glaucoma Service

Stanford University

Unknown-1.jpeg

Arthur Sit, MD, FAAO

Mayo Clinic

Unknown.jpeg

Robert Stamper, MD

University of California

San Francisco

Yancey-1.jpg

Charles Yancy, MD, Ph.D.

West Metro Ophthalmology

97afa0_816609412da844bf8f31286199d3febe.jpg.webp

Myron Yanoff, MD, FAAO

Chair Emeritus Ophthalmology

Scheie Eye Institute

INVESTMENT

Partnering with Major Strategics

Injectsense partners with major strategics who understand that autonomous, continuous monitoring of key markers will change the standard of care and improve disease outcomes through evidence-supported therapies.

iStock-1382523426.jpg

Injectsense Timeline

2014

INJECTSENSE IS FOUNDED

Following extensive experience in semiconductor-based medical device development for a range of major clients and applications, Injectsense co-founders develop the idea for a new in-vivo sensor platform. After soliciting industry feedback to poke holes in the idea, they decide the platform is viable and form the company. 

2016

SEED FUNDING SECURED AND DESIGN BEGINS  

The company raised significant seed funding, assembled its team of microelectronics and systems experts, and began development. 

iStock-1189899412.jpg
bottom of page